Study of the ENTact Septal Staple System for Tissue Approximation During Septoplasty

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00740480
Recruitment Status : Completed
First Posted : August 25, 2008
Results First Posted : August 21, 2009
Last Update Posted : August 25, 2009
Information provided by:
ENTrigue Surgical, Inc.

Brief Summary:
The purpose of this research study is to learn more about the ENTact™ Septal Staple System device performance and to collect information to support its premarket application.

Condition or disease
Nasal Septum

Detailed Description:

The ENTact™ Staple System is a device that inserts a small staple or tack to hold mucosa (moist tissues) in place instead of using stitches. The staple gradually dissolves and does not need to be removed. This clinical study will evaluate:

  • surgical performance of the ENTact Septal Staple System
  • one week post op clinical evaluation of gross tissue appearance at implantation site(s)
  • ENTact™ Septal Staple functionality based on maintained coaptation

Study Type : Observational
Actual Enrollment : 25 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: A Prospective, Non-Randomized, Limited-Use Evaluation of the ENTact Septal Staple System for Tissue Approximation During Septoplasties
Study Start Date : April 2008
Actual Primary Completion Date : February 2009
Actual Study Completion Date : February 2009

Adult population (ages 18-65) with clinically significant nasal septum deviation.

Primary Outcome Measures :
  1. Coaptation (Tissue Approximation) [ Time Frame: One week post surgery ]

Secondary Outcome Measures :
  1. Tissue Reaction to Implant [ Time Frame: One week post surgery ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Adult patients (ages 18-65) with clinically significant nasal septum deviation.

Inclusion Criteria:

  • Adult patients, between the ages of 18 and 65 years, with a clinically significant deviation of the nasal septum
  • Patient is able to provide a signed informed consent form
  • Patient will agree to comply with all study related procedures
  • Patient is not pregnant at this time. If patient is of child-bearing age and capable of bearing children, a pre-operative pregnancy test confirmation is required to show that patient is not pregnant on the day of surgery
  • Patient does not plan on becoming pregnant and is not breast feeding during the course of the study

Exclusion Criteria:

  • Patients who do not meet the inclusion criteria
  • Patients who have had previous septoplasty
  • Patients with uncontrolled diabetes
  • Presence of infection at the site
  • Smokers and severe drug and alcohol abusers
  • Patients with autoimmune disease deemed clinically significant by Principal Investigator

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00740480

United States, Ohio
Good Samaritan Hospital
Cincinnati, Ohio, United States, 45220
United States, Texas
Park Hudson Surgery Center
Bryan, Texas, United States, 77802
Physician's Ambulatory Surgery Center IV
San Antonio, Texas, United States, 78258
Sponsors and Collaborators
ENTrigue Surgical, Inc.
Study Director: Gabriele G Niederauer, Ph.D. ENTrigue Surgical, Inc.

Responsible Party: Gabriele Niederauer, Ph.D./Vice President, Research and Development, ENTrigue Surgical, Inc. Identifier: NCT00740480     History of Changes
Other Study ID Numbers: CSA 2008-01
First Posted: August 25, 2008    Key Record Dates
Results First Posted: August 21, 2009
Last Update Posted: August 25, 2009
Last Verified: August 2009

Keywords provided by ENTrigue Surgical, Inc.: